Evidence map›Paper›PMID 26723564›Full record

ReviewBrain research2016

Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Cole Vonder Haar, Todd C Peterson, Kris M Martens, Michael R Hoane

Registry-linked trialAbstract readReview
In one paragraph

Review in Brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05589064 (Evaluation of the Impact of a Dietary and Nutritional Intervention on the Physical, Cognitive, Behavioural and Emotional Symptoms of Patients With Persistent Post-concussive Symptoms), which is not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05589064 narecruitingnot on this mapstarted 2022, after this paper: background citation

Evaluation of the Impact of a Dietary and Nutritional Intervention on the Physical, Cognitive, Behavioural and Emotional Symptoms of Patients With Persistent Post-concussive Symptoms

TypeinterventionalSponsorUniversite de MonctonRan2022 to 2025Enrolled120ConditionsBrain Injury Traumatic MildArmsExperimental: Dietetic counseling, Active Comparator: Omega-3, vitamin D3 and creatine monohydrate, Other : Physiotherapy treatment
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. The Gut Microbiome as a Modulator of Traumatic Brain Injury Pathology and Symptoms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Antioxidant therapies in traumatic brain injury.Neurochemistry international · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Nutrition in the Neurocritical Care Unit: a New Frontier.Current treatment options in neurology · 2021
    Review
  16. Review
  17. Antioxidant Therapies in Traumatic Brain Injury.Antioxidants (Basel, Switzerland) · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Cole Vonder HaarUniversity of British Columbia, Vancouver, BC, Canada.
Todd C PetersonStanford University, Palo Alto, CA, USA.
Kris M MartensUniversity of British Columbia, Vancouver, BC, Canada.
Michael R HoaneSouthern Illinois University, Carbondale, IL, USA. Electronic address: mhoane@siu.edu.
University of British Columbia · CASouthern Illinois University Carbondale · USStanford University · US

Funding

Pharmacological Optimization of Poly-Drug Therapy in Traumatic Brain InjuryR01HD061944 · NICHD · UNIVERSITY OF WASHINGTON · PI ANDERSON, GAIL, HOANE, MICHAEL R. · 2009 to 2013
$3.1M
The Effects of Vitamin B3 on Traumatic Brain InjuryR15NS045647 · NINDS · SOUTHERN ILLINOIS UNIVERSITY CARBONDALE · PI HOANE, MICHAEL R. · 2003 to 2009
$596k
NICHD NIH HHS R01 HD061944NINDS NIH HHS R15 NS045647
6 · The paper itself

Abstract

With the numerous failures of pharmaceuticals to treat traumatic brain injury in humans, more researchers have become interested in combination therapies. This is largely due to the multimodal nature of damage from injury, which causes excitotoxicity, oxidative stress, edema, neuroinflammation and cell death. Polydrug treatments have the potential to target multiple aspects of the secondary injury cascade, while many previous therapies focused on one particular aspect. Of specific note are vitamins, minerals and nutrients that can be utilized to supplement other therapies. Many of these have low toxicity, are already FDA approved and have minimal interactions with other drugs, making them attractive targets for therapeutics. Over the past 20 years, interest in supplementation and supraphysiologic dosing of nutrients for brain injury has increased and indeed many vitamins and nutrients now have a considerable body of the literature backing their use. Here, we review several of the prominent therapies in the category of nutraceutical treatment for brain injury in experimental models, including vitamins (B2, B3, B6, B9, C, D, E), herbs and traditional medicines (ginseng, Gingko biloba), flavonoids, and other nutrients (magnesium, zinc, carnitine, omega-3 fatty acids). While there is still much work to be done, several of these have strong potential for clinical therapies, particularly with regard to polydrug regimens. This article is part of a Special Issue entitled SI:Brain injury and recovery.

Indexed as

Dietary SupplementsAnimalsBrain InjuriesHumansNeuroprotective AgentsVitaminsNeuroprotective AgentsVitaminsMineralsNutrientsPolytherapyTBIVitamins

Identifiers

PMID26723564
PMCPMC4870112
OpenAlexW2217487786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.